Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK

Jameel Nazir,Malin Berling,Charles McCrea,Francis Fatoye,Sally Bowditch,Zalmai Hakimi,Adrian Wagg

Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK

2017

Jameel Nazir
Malin Berling
Charles McCrea
Francis Fatoye
Sally Bowditch
Zalmai Hakimi
Adrian Wagg

Purpose Our objective was to estimate the economic outcomes of using mirabegron versus antimuscarinics in the treatment of patients with overactive bladder (OAB) from a societal perspective in the UK.

Keywords:

Solifenacin
Mirabegron
Overactive bladder
Urology
Oxybutynin
Economic impact analysis
Surgery
Tolterodine
Medicine
Intensive care medicine
immediate release
societal perspective

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations